Literature DB >> 30927243

Correction to: Breast cancer cell motility is promoted by 14-3-3γ.

Emiko Hiraoka1, Takahiro Mimae2, Masaoki Ito1, Takayuki Kadoya1, Yoshihiro Miyata1, Akihiko Ito3, Morihito Okada1.   

Abstract

The correct name of the corresponding author should be ''Takahiro Mimae'', and not ''Emiko Hiraoka'' as given in the original publication of the article.

Entities:  

Year:  2019        PMID： 30927243     DOI： 10.1007/s12282-019-00964-5

Source DB:  PubMed          Journal:  Breast Cancer        ISSN： 1340-6868            Impact factor:   4.239


  3 in total

1.  Proteomics Approach of Rapamycin Anti-Tumoral Effect on Primary and Metastatic Canine Mammary Tumor Cells In Vitro.

Authors:  Patrícia F Lainetti; Antonio F Leis-Filho; Priscila E Kobayashi; Laíza S de Camargo; Renee Laufer-Amorim; Carlos E Fonseca-Alves; Fabiana F Souza
Journal:  Molecules       Date:  2021-02-25       Impact factor: 4.411

2.  TXNDC9 knockdown inhibits lung adenocarcinoma progression by targeting YWHAG.

Authors:  Jing Wang; Xiaotao Pan; Jie Li; Jin Zhao
Journal:  Mol Med Rep       Date:  2022-04-29       Impact factor: 2.952

Review 3.  Role of Deubiquitinases in Human Cancers: Potential Targeted Therapy.

Authors:  Keng Po Lai; Jian Chen; William Ka Fai Tse
Journal:  Int J Mol Sci       Date:  2020-04-06       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.